DRAK2 抗体 (C-Term)
Quick Overview for DRAK2 抗体 (C-Term) (ABIN1882073)
抗原
See all DRAK2 (STK17B) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 342-371, C-Term
- 
                                            纯化方法
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- 
                                            免疫原
- This DRAK2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 342-371 amino acids from the C-terminal region of human DRAK2.
- 
                                            亚型
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- IF: 1:10~50. WB: 1:1000. IHC-P: 1:50~100
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - 
                                            : "Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation."    in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 8, pp. 4762-70, (2009)         (PubMed).        
 : "Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development." in: The Journal of biological chemistry, Vol. 281, Issue 18, pp. 12587-95, (2006) (PubMed).
 : "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, (1998) (PubMed).
 
 
- 
                                            : "Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation."    in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 8, pp. 4762-70, (2009)         (PubMed).        
- 
    - DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- 
                                            别名
- DRAK2
- 
                                            背景
- DRAK2 is a novel serine/threonine kinase that induces apoptosis via catalytic activity. DRAKs present high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases. DRAK2 is located in nucleus, and the messenger RNA is ubiquitously expressed in human tissues.
- 
                                            分子量
- 42344
- 
                                            NCBI登录号
- NP_004217
- 
                                            UniProt
- O94768
 抗原
- 
                    
 
                                     
                                     
                                    